Portfolio Archive - Page 10 of 60 - Bryan, Garnier & Co

Bryan, Garnier & Co acts as Sole Financial Advisor to the Shareholders of Däckskiftarna in the merger with Bythjul, a portfolio company of French investment group Mobivia

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on a €20m secondary offering of HRS shares

Bryan, Garnier & Co acts as Sole Financial Advisor to Mint Media and its shareholders on the sale of Mint Media to Aleven

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Egetis Therapeutics' Nasdaq Stockholm SEK 210 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to Indosuez Wealth Management on the acquisition of Wealth Dynamix

Bryan, Garnier & Co acts as Sole Financial Advisor to Selfapy, one of the leading providers in digital therapeutics for mental health disorders in Germany, on its growth financing from strategic investor Medice Arzneimittel and existing shareholders

Bryan, Garnier & Co advises Carlyle on its investment in Groupe Lacour

Bryan, Garnier & Co acts as Sole Bookrunner on Oncodesign Precision Medicine's EUR 8 million Follow-on Offering & IPO on Euronext Growth Paris

Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on the acquisition of the Machine & Perfusion division from Avionord S.r.l.

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Nicox' Euronext Paris EUR 10 million Follow-on Offering & Warrants issuance

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }